FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.

2.

Small Renal Mass Surveillance Does Not Affect Nephron-Sparing Surgery.

3.

Error on the MGUS-Autoimmune Disease Association.

4.

A video animation guide to assist young people who are fatigued from cancer.

5.

Early Results for Anorexia Nervosa with Psilocybin.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot